Fridjonsdottir, E., Shariatgorji, R., Nilsson, A., Vallianatou, T., Odell, L. R., Schembri, L. S., . . . Andrén, P. E. (2021). Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA–induced dyskinesia. Sci Adv.
Chicago ZitierstilFridjonsdottir, Elva, et al. "Mass Spectrometry Imaging Identifies Abnormally Elevated Brain L-DOPA Levels and Extrastriatal Monoaminergic Dysregulation in L-DOPA–induced Dyskinesia." Sci Adv 2021.
MLA ZitierstilFridjonsdottir, Elva, et al. "Mass Spectrometry Imaging Identifies Abnormally Elevated Brain L-DOPA Levels and Extrastriatal Monoaminergic Dysregulation in L-DOPA–induced Dyskinesia." Sci Adv 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.